v3.25.2
Stock-Based Compensation
6 Months Ended
Jun. 28, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

12. STOCK-BASED COMPENSATION

On April 12, 2021, the Company’s stockholders approved the Latham Group, Inc. 2021 Omnibus Equity Incentive Plan (the “2021 Omnibus Equity Plan”), which became effective on April 22, 2021. The 2021 Omnibus Equity Plan provides for the issuance of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance stock units and other stock-based and cash-based awards. The maximum grant date fair value of cash and equity awards that may be awarded to a non-employee director under the 2021 Omnibus Equity Plan during any one fiscal year, together with any cash fees paid to such non-employee director during such fiscal year, is $750,000.

On May 2, 2023, at the 2023 annual meeting of stockholders of the Company, the stockholders approved the first amendment (the “Equity Plan First Amendment”) to the 2021 Omnibus Equity Plan, which was previously approved by the Board of Directors of the Company (the “Board”). The Equity Plan First Amendment became effective upon stockholder approval, and provides for (i) an increase by 8,000,000 shares of the share pool, i.e. the maximum number of shares of the Company’s common stock that may be issued pursuant to awards granted under the 2021 Omnibus Equity Plan, (ii) a prohibition on recycling shares withheld or remitted to pay taxes for all awards, (iii) a minimum vesting period of one year for all awards, with an exception for shares representing 5% of the share pool and (iv) a prohibition on the transfer of stock options and stock appreciation rights for value or to third-party financial institutions without stockholder approval.

Except as amended by the Equity Plan First Amendment, the other terms of the 2021 Omnibus Equity Plan remain in full force and effect. Subsequent to the Equity Plan First Amendment, the maximum aggregate number of shares reserved for issuance under the 2021 Omnibus Equity Plan is 21,170,212 shares.

The following table summarizes the Company’s stock-based compensation expense (in thousands):

Fiscal Quarter Ended

Two Fiscal Quarters Ended

    

June 28, 2025

    

June 29, 2024

June 28, 2025

    

June 29, 2024

Selling, general, and administrative

$

1,381

$

2,100

$

3,352

$

3,343

As of June 28, 2025, total unrecognized stock-based compensation expense related to all unvested stock-based awards was $12.6 million, which is expected to be recognized over a weighted-average period of 2.0 years.

Restricted Stock Units

The following table represents the Company’s restricted stock units activity during the two fiscal quarters ended June 28, 2025:

    

    

Weighted-

Average Grant-

Shares

Date Fair Value

Outstanding at January 1, 2025

 

4,200,759

$

3.12

Granted

 

900,836

 

7.12

Vested

 

(1,123,711)

 

3.12

Forfeited

 

(394,117)

 

3.73

Outstanding at June 28, 2025

 

3,583,767

$

4.06

Stock Options

The following table represents the Company’s stock options activity during the two fiscal quarters ended June 28, 2025:

    

Weighted-

    

Weighted-

    

Average 

Average 

Exercise Price

Remaining 

Aggregate 

    

Shares

    

 per Share

    

Contract Term

    

Intrinsic Value

 

 

(in years)

(in thousands)

Outstanding at January 1, 2025

 

1,383,738

$

15.20

 

Granted

 

 

  

 

  

Exercised

 

 

 

  

 

  

Forfeited

 

(34,719)

15.38

 

  

 

  

Expired

Outstanding at June 28, 2025

 

1,349,019

$

15.20

 

5.57

$

104

Vested and expected to vest at June 28, 2025

 

1,349,019

$

15.20

 

5.57

$

104

Options exercisable at June 28, 2025

 

1,097,147

$

16.05

 

5.28

$

52

The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those stock options that had exercise prices lower than the fair value of the Company’s common stock.

Stock Appreciation Rights

The following table represents the Company’s stock appreciation rights activity during the two fiscal quarters ended June 28, 2025:

    

Weighted-

    

Weighted-

    

Average 

Average 

Exercise Price

Remaining 

Aggregate 

    

Shares

    

 per Share

    

Contract Term

    

Intrinsic Value

 

 

(in years)

(in thousands)

Outstanding at January 1, 2025

 

660,556

$

3.15

 

Granted

 

 

  

 

  

Exercised

 

 

 

  

 

  

Forfeited

 

(73,027)

 

3.24

 

  

 

  

Outstanding at June 28, 2025

 

587,529

$

3.14

 

6.93

$

2,023

Vested and expected to vest at June 28, 2025

 

587,529

$

3.14

 

6.93

$

2,023

Stock appreciation rights exercisable at June 28, 2025

 

292,602

$

3.19

 

5.94

$

992

The aggregate intrinsic value of stock appreciation rights is calculated as the difference between the strike price of the stock appreciation rights and the fair value of the Company’s common stock for those stock appreciation rights that had strike prices lower than the fair value of the Company’s common stock.

Performance Stock Units

During the two fiscal quarters ended June 28, 2025, the Compensation Committee of the Board approved the grant of performance stock units (“PSUs”) as a portion of the annual equity award to the Company’s executive officers.

Thirty-three percent of the target number of PSUs awarded on the grant date will be earned annually at 0% to 200% of the target number of PSUs based on the Company’s achievement of Adjusted EBITDA (with 100% of PSUs being earned at target performance, and linear interpolation between threshold and target and maximum performance) as defined in the award agreement, for each year of the three-year performance period beginning January 1, 2025 and ending December 31, 2027. Any earned PSUs cliff vest on the third anniversary of the grant date. Adjusted EBITDA is considered a performance condition and the grant date fair value corresponds with management’s expectation of the probable outcome of the performance condition as of the grant date. The grant date fair value was determined based on the fair market value of the Company’s stock at market close on the grant date multiplied by the target number of shares subject to the award and adjusted for management’s expectation of the probable outcome of the performance condition. The probability of achieving the performance criteria is assessed quarterly during the performance period. Compensation expense related to unvested PSUs is recognized ratably over the performance period.

The following table represents the Company’s PSU activity during the two fiscal quarters ended June 28, 2025:

    

 

Weighted-

 

Average 

 

Grant Date

    

Shares

    

 

Fair Value

 

 

Outstanding at January 1, 2025

 

807,771

$

2.91

Granted

 

325,613

7.33

Adjustment for performance achievement (1)

 

Forfeited

 

(182,521)

3.67

Outstanding at June 28, 2025 (2)

 

950,863

$

4.28

(1)Represents the adjustment to previously granted PSUs based on the Company’s performance expectations as of the end of each respective fiscal year.

(2)An additional 292,870 PSUs could potentially be included if the maximum performance level of 200% is earned for all PSUs granted on or after January 1, 2025 and outstanding as of June 28, 2025.